• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

High-dose exercise therapy is not superior to low-dose exercise therapy for knee osteoarthritis

byBryant LimandKiera Liblik
February 3, 2023
in Chronic Disease, Orthopedic Surgery
Reading Time: 3 mins read
Physical therapy reduces pain in adults with knee osteoarthritis
Share on FacebookShare on Twitter

1. In this randomized control trial of knee osteoarthritis patients, there was no significant difference between high-dose and low-dose exercise therapy for Knee injury and Osteoarthritis Outcome Scores (KOOS). 

2. No significant difference between groups was found in patient experience of pain intensity or quality of life.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Knee osteoarthritis can significantly impact patient quality of life through chronic joint pain, knee stiffness, and decreased functioning. While exercise is recommended for osteoarthritis treatment, it is unclear the optimal dose of exercise therapy. This randomized clinical trial compared high-dose and low-dose exercise therapy for patients with knee osteoarthritis. High-dose therapy was defined as 11 exercises over 70 to 90 minutes. Low-dose therapy was defined as five exercises over 20 to 30 minutes. Patients exercised three times per week for 12 weeks, and then followed up at six and 12 months. The primary outcome was the difference in the KOOS, which measured pain, symptoms, function in daily living, function in Sport/Rec, and knee-related quality of life, at three months from baseline. The secondary outcome was the Visual Analogue scales (VASs) for pain and the index and VAS from the EuroQoL Group 5-Dimension (EQ-5D) tool for health-related quality of life. For the primary outcome, while patients in both groups improved on the KOOS, there were no significant differences between groups. The high-dose therapy group scored significantly higher KOOS Sports/Rec subscale at the end of the intervention and at six months follow-up. No significant differences were found for the VASs and EQ-5D scores at any of the follow-ups. As a limitation, there was no control group and therefore, the true benefit of exercise therapy was unable to be assessed.

Click to read the study in AIM

In-Depth [randomized controlled trial]: This randomized controlled clinical trial assessed the efficacy of high-dose versus low-dose exercise therapy for improving quality of life and symptoms in knee osteoarthritis patients. A total of 189 patients aged 45 to 85 with knee osteoarthritis and a history of knee pain with decreased function were randomized to receive either high-dose (n = 98) or low-dose (n = 91) exercise therapy. Exercise therapy was administered three times per week over 12 weeks in both groups. In the high-dose exercise therapy group, sessions consisted of  11 exercises over 70 to 90 minutes per session. Conversely, the low-dose exercise therapy group received five exercises over 20 to 30 minutes. Patients were followed up at both six and 12 months after the intervention. For the primary outcome, there were no significant differences between groups in the KOOS at any point of follow-up. However, the KOOS Sport/Rec subscale score was significantly higher in the high-dose therapy group compared to the low-dose therapy group at the end of the intervention (Mean Difference [MD], 8; 95% Confidence Interval [CI], 2 to 14) and at six months after intervention (MD, 11; 95% CI, 4 to 17). The significant difference was not sustained at 12 months follow-up. For the secondary outcome, there were no differences in mean score for the pain intensity (VAS) score or quality of life (EQ-5D) scores. The results from this study did not support the superiority of high-dose exercise therapy over low-dose exercise therapy for knee osteoarthritis patients.

RELATED REPORTS

Continuous femoral nerve block is not superior to continuous adductor canal block for postoperative pain following ACL reconstruction

2 Minute Medicine Rewind Aug 24th, 2026 

Joint fusion superior to watchful waiting for hallux rigidus 

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic diseaseexercise therapyhigh-dose exercise therapykneo osteoarthritislow-dose exercise therapyorthopedic surgeryosteoarthritis
Previous Post

Subcuticular sutures following elective hepatobiliary surgery may reduce site infections

Next Post

#VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension

RelatedReports

Social networks play key roles in parental vaccination decisions
Imaging and Intervention

Continuous femoral nerve block is not superior to continuous adductor canal block for postoperative pain following ACL reconstruction

September 7, 2026
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Weekly Rewinds

2 Minute Medicine Rewind Aug 24th, 2026 

August 26, 2026
Uninterrupted warfarin therapy safe for endovascular procedures
Orthopedic Surgery

Joint fusion superior to watchful waiting for hallux rigidus 

August 10, 2026
Amyloid may cause distant cerebral hypometabolism in Alzheimer’s
Psychiatry

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

September 4, 2026
Next Post
#VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension

#VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension

Intravenous contrast may not increase risk of acute kidney injury

Cystatin C-based equation without race or sex improves accuracy of GFR estimation

Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease

Dual antiplatelet therapy discontinued 9 months after percutaneous coronary intervention associated with improved morbidity and mortality

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.